The Power of Neuroplastogens

The Delix platform—our path to novel neuroplastogens

The Delix discovery platform serves to rapidly identify novel oral neuroplastogens that promote circuit-selective, structural, and functional neuroplasticity, while avoiding hallucinations, dissociation, or cardiotoxicity.

  • Rapid and sustained

    All of Delix's compounds are intended to be fast acting and long lasting

  • Convenient

    All Delix compounds are developed to be oral medications taken at home without the need for supervision, monitoring, or administration technology

  • Scalable

    By eliminating the hallucinogenic traits of our compounds and making them orally bioavailable, the Delix platform allows for maximum scalability across indications and patient types to give access to a larger addressable population

View our pipeline